Financials
Financial year 2025
DYNA DISTRIBUTION from Gent, company number BE1008200182, closed financial year 2025 with a result of € 158 after tax. For that financial year DYNA DISTRIBUTION recorded a gross margin of € 2,191 and equity of € 3,158. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 3,158
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 158
Profit after tax over the fiscal year.
€ 7,016
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 158.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,430
Supplier invoices still open on the last day of the fiscal year.
€ 536
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about DYNA DISTRIBUTION the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DYNA DISTRIBUTION?
What happened at DYNA DISTRIBUTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 158. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
- Decura Pharma BV became a director. NBB
In short
Paid € 53 in corporate taxes since 2025.
Management
The stake of DECURA PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DYNA DISTRIBUTIONBehind DYNA DISTRIBUTION is Decura Pharma BV. The shares are held by DECURA PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Andy Decuypere
Also active at: MEDISALE, Deraphar, LINDEPHAR, APOTHEEK RAES, FIDELMED, PHARMA FIDELMED, HEALTH AND BEAUTY SHOP
since 2024
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Waalkens 11b
9030 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in East Flanders
Same main activity (Groothandel in farmaceutische en medische artikelen), 196 active companies in East Flanders, largest first.
€ 1.8 billion revenue · 2025 · Sint-Niklaas
€ 278.3 million revenue · 2025 · Sint-Niklaas
€ 44.6 million revenue · 2025 · Gent
€ 35.3 million revenue · 2025 · Gent
€ 34.5 million revenue · 2024 · Gent
€ 32.9 million revenue · 2025 · Gent
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DECURA PHARMA(oprichter) 100%
Details
- Company number
- 1008.200.182
- VAT number
- BE 1008.200.182
- Registered office
- Waalkens 11b, 9030 Gent
- Names & denominations
- DYNA DISTRIBUTION
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 April 2024
- Peppol
- Active · Active since 17 Jun 2025
- Contact
- [email protected]
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in parfumerieën en cosmetica